Graphic abstract

Review Ascites-Derived Organoids: Emerging Models for Drug Resistance and Personalized Therapy Tingting Liu, Fayong Ke, Yixian Wang, Yuan Dang, Qianhui Xu J. Cancer 2026; 17(12): 2154-2168. doi:10.7150/jca.136865 Full text PDF


Graphic abstract

Research Paper Integrative Multi-Cohort and Single-Cell Analyses Identify KIF11 as a Prognostic and Immune-Cold Marker in Lung Adenocarcinoma Wenbin Jia, Zewei Zhao, Chunlan Ning, Jiaqi Zhou, Bowen Liu, Xinchao Li, Yu Zou, Xuchen Cao, Xin Wang, Yue Yu J. Cancer 2026; 17(12): 2137-2153. doi:10.7150/jca.141576 Full text PDF


Graphic abstract

Research Paper Co-targeting Aurora Kinase A and DNA Damage Response Pathways Enhances Apoptotic Cell Death in Cholangiocarcinoma Cells Benchamart Moolmuang, Mathuros Ruchirawat J. Cancer 2026; 17(12): 2126-2136. doi:10.7150/jca.142715 Full text PDF


Graphic abstract

Review Lung Cancer Evolves as an Ecosystem from Niche Dysregulation to Metastasis and Treatment Resistance Jie Wu, Youyi Ding, Peiliang Huang, Yan Chen, Shuo Chen J. Cancer 2026; 17(12): 2103-2125. doi:10.7150/jca.143837 Full text PDF


Graphic abstract

Review The Roles of Vitamins in Cancer Initiation, Progression, and Therapy: Clinical Evidence, Molecular Mechanisms, and Precision Translation Fanglin Liu, Anqi He, Liang Zhou, Yong Xia, Xuyi Wu, Fuyan Xu J. Cancer 2026; 17(12): 2082-2102. doi:10.7150/jca.141758 Full text PDF


Graphic abstract

Research Paper Real-World Experience with Neoadjuvant Treatment for Stage I-III Non-Small Cell Lung Cancer: A Single-Center Cohort Study and TriNetX database Yi-Wen Chen, Cheng-Yen Chuang, Chih-Hung Lin, Yen-Hsiang Huang, Kuo-Hsuan Hsu, Po-Hsin Lee, Tsung-Ying Yang, Jeng-Sen Tseng, Shun-Fa Yang J. Cancer 2026; 17(12): 2071-2081. doi:10.7150/jca.142595 Full text PDF

More ...

Issue 11; 2026

Cover image

Indexed in PubMed and SCI expanded; full texts in Europe PMC. ...


Ascites-Derived Organoids: Emerging Models for Drug Resistance and Personalized Therapy

Traditional two-dimensional cell models and animal models struggle to replicate tumor heterogeneity and microenvironment interactions. Existing treatments have low efficiency, high recurrence rates and no personalized regimens. Malignant Ascites-Derived Organoids (MADOs), three-dimensional models constructed from tumor cells isolated from malignant ascites, can highly preserve the histological features, molecular expression profiles, genomic landscapes, ...


Integrative Multi-Cohort and Single-Cell Analyses Identify KIF11 as a Prognostic and Immune-Cold Marker in Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) is characterized by substantial molecular heterogeneity and marked differences in clinical outcome and therapeutic response. Although the mechanical microenvironment contributes to tumor progression and immune regulation, the prognostic and immunological relevance of mechanobiology-related genes in LUAD remains incompletely understood. In this study, we integrated transcriptomic, clinical, genomic, immunotherapy, and single-cell ...

Popup Image